Skip to content
Delayed ~15 min

NKTR NEKTAR THERAPEUTICS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · after market close

What 17 analyst firms say about NEKTAR THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

37.26 USD+1.11 (+3.07%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+239.2%to the avg target 126.38 USD+89.12 USD
Buy 12 · Hold 4 · Sell 0

16 rated views · 18 analyst/firm records · 17 firms

Latest report12 Oct 2026avg report date 27 Jul
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8053
  • Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8041

Recent analyst activity · last 90 days

Our tracked history has 16 reports on NKTR from 9 analyst firms in the last 90 days (17 firms in the past year).

Comparing each firm's latest target with its previous one: 3 left it unchanged and 3 have their first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Wedbush lowered its target from $80.00 (set 11 May 2026) to $50.00 on 14 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesMayank MamtaniBuy22 Jul 2026150.00 USD
BTIGJulian HarrisonBuy9 Oct 2026178.00 USD
Canaccord GenuityEdward NashBuy22 Jul 2026153.00 USD
CitigroupSamantha SemenkowBuy21 Apr 2026151.00 USD
H.C. WainwrightArthur HeBuy2 Oct 2026185.00 USD
JefferiesRoger SongBuy22 Apr 2026150.00 USD
JPMorganJessica FyeHold21 Aug 202665.00 USD
Leerink PartnersWill SoghikianBuy12 Oct 2026130.00 USD
OppenheimerJay OlsonBuy13 Mar 2026140.00 USD
Piper SandlerYasmeen RahimiBuy24 Jul 2026192.00 USD
Raymond JamesThomas DealConflictConflicting reports · excluded9 Oct 2026—
TD CowenMarc FrahmBuy24 Aug 2026—
TD CowenTara BancroftBuy24 Aug 2026—
UBSAlice NettletonHold12 Oct 202653.00 USD
WedbushMartin FanHold23 Sep 202650.00 USD
Weiss RatingsUnnamed analyst—28 Aug 2026—
William BlairAndy T HsiehBuy13 Jul 2026—
Data feed RESEARCHResearch TeamHold15 Jun 202646.00 USD

Partial coverage · checked 6 Nov (6 Nov 2026, 05:53 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.